Actelion diarrhea treatment gets fast-track from U.S. FDA

ZURICH (Reuters) – Actelion Ltd, Europe's biggest biotech company, said on Thursday that the U.S. health regulator has granted fast-track status to its antibiotic treatment for diarrhea. A fast track designation by the U.S. Food and Drug Administration (FDA) speeds up regulatory review of drugs that aim to treat serious diseases and fill unmet medical needs. Actelion said the FDA was also …
FDA News – Yahoo News Search Results

Pharmaceutical Stocks


© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us